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Introduction  
 
Diabetes is a chronic condition that occurs when the pancreas does not produce 
enough insulin or when the body cannot effectively use the insulin it produces. 
People having type 1 diabetes require insulin (10% of all diabetics). People with type 2 
diabetes can be treated with oral medication, but may also require insulin; 10% of all 
type 2 diabetics require insulin. Among the actual different methods to administer 
insulin (syringes, pens and conventional infusion pumps) a possibility to increase 
infuser performances is offered by the utilization of silicon based MEMS pumps (Micro-
Electro Mechanical Systems). The main two pump families are classified as 
mechanical and non-mechanical pumps. The former contains check-valve, peristaltic, 
rectification without valves and rotary ones (“Displacement Pumps”) or Ultrasonic and 
Centrifugal (“Dynamic Pumps”); the latter consists in Pressure, Concentration, 
Electrical Potential gradients and Magnetic Potential micro-pumps. 
The micro-pump described here is an electro-mechanical device actuated with a 
piezoelectric-element and based on MEMS technology, able to minimize size and 
costs, offering a high precision pharmacological dispense [1]. Three slices are bonded 
to reach the final results: top and bottom caps and an intermediate SOI. In case of 
anodic bonding, top and bottom caps are constituted of micromachined 
borophosphosilicate wafers, whereas in case of metallic bonding three silicon slices 
are used. The paper deals with the fabrication evolution of the device according to the 
different items that had to be faced during development: design, fluidic, mechanical 
and electrical simulations and characterization, safety requirements and final testing. 
Built-in reliability is ensured by two inner sensors able to detect any occlusion or 
malfunctioning and informing so the patient. The result is a compact, core pump chip 
that can deliver from 0.02 Units of insulin up to 3.6 Units per minute with accuracy 
better than 5%. 
 
1. Full Device General Characteristics 
 
The insulin dispense device consists of a disposable and a permanent part. The 
disposable part mainly features a plastic shell containing the MEMS insulin micro-
pump, the actuator and the insulin reservoir. The permanent part is basically made of a 
plastic shell containing the electronics with embedded firmware and the wireless 
control board (Fig. 1). In fact the basal or the bolus insulin amount can be pre-
programmed by a remote control via RF connection. The device is fitted on a patch 
located on the patient’s arms or abdomen. The pump can be attached to or detached 
from the infusion cannula through-skin inserted. 
Schematic cross-sections of the pump in pull (filling) and push (infusion) actuation 
phases are provided in Fig. 2 and 3 respectively. During pulling the inlet valve opens 
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and the outlet one remains closed, whereas while the actuator is pushing the pumping 
membrane the outlet opens, closing the inlet.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Design and Simulations 
 
The design of the MEMS device has been focused on fluidic, mechanical, and 
electrical requirements. For fluidic dynamics active and dead volumes have been 
dimensioned and also the insulin fluidic pathway and flow have been calculated on the 
basis of the desired pharmacological delivery. In particular way solid structures have 
been placed all along the fluidic path in order to provide continuous, laminar and not 
turbulent liquid flow. As far as electrical design is concerned, the simulations have 
been used to reach proper implant doses for p-n junctions, sheet and ohmic contact 
resistances, diffusion depth, sensor balancing, and parasitic effect account. Finally 
also mechanical behavior was modeled and performances calculated so that stroke 
 
Figs.1: Pump chip (top) 
and insulin dispense 
device (bottom). 
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Fig.2: Pump actuation 
 in pull mode. 
Fig.3: Pump actuation 
 in push mode. 
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The device is sealed by an inner 
and an outer metallic ring 
providing sealing to the pump 
cavity, fluidic path and dead 
volumes (Fig. 4).  
Built-in detectors monitor each 
pump beat detecting any 
occlusion or malfunctions almost 
instantaneously. Another sensor 
controls the temperature inside 
the pump: exposure to external 
heating will be signaled as 
warning before possible insulin 
degradation occurs. 
 
 
Fig.4: pump chip IR picture; clearly visible 
the inner and outer metallic bonding rings. 
volume and pumping membrane reliability reached the target specifications. In Fig. 5 it 
is reported a FEM simulation showing the strain and the stress induced on metal buses 
and silicon by the bonding operation itself.  
 
  
 
 
 
 
Pump inlet valve, normally closed, is maintained under pre-tension by means of arm 
springs and an apposite counter-bouncing ring. Arm length optimization and relative 
mechanical stress were also calculated through FEM simulations in order to ensure 
that the device can be submitted to a shock equivalent to a drop of several meters 
without damage. The mechanical integrity of the micropump is monitored during the 
functioning of the device by testing electrically crack-guard rings implanted directly into 
each moving parts of the MEMS pump. 
Several technological aspects have been coped to achieve the final MEMS device: 
- Cavity etch to get repeatable and precise pumping volume; 
- Front to backside alignment for lithographic masking operations; 
- Pass through holes into 500 µm thick wafers; 
- Ion Implantation simulations of the different atomic species doses to achieve the 
desired electronic characteristics of the passive elements inside the MEMS 
device; 
- Membrane and valve freed by HF release step; 
- Thin wafer handling and processing; 
- Stacking of three slices: bonding alignment and tightness; 
- Physical and chemical material compatibility and choice. 
In particular way original wafer finishing solutions were found in order to obtain clean 
and bondable surfaces. 
 
 
3. MEMS Characterization (Fluidic, Mechanical, Electrical) 
 
MEMS pump fluidic characterization has been performed through laboratory 
equipment in order to study delivery both in dry and wet mode. Liquid delivery 
repeatability and accuracy were verified by means of gravimetric measurements, 
Figs. 5: Top cap metallic bonding simulation: strength (in blue) and weakness zones (in 
orange red) for displacement and pressure parameters, r spectively (in A.U.). 
Displacement Pressure 
whereas dry tests were carried out using digital precision manometer and pressure 
regulator, interfaced to a computer. 
 
 
 
 
 
 
 
 
4. Technological Key Items for Process Integration 
 
In Fig. 6 the evolutions of the stroke volume versus the flow rate and the reservoir 
pressure are shown, indicating that the delivery accuracy does not depend on 
actuation frequency up to 3 Hz and inlet pressure in the range +/- 300 mbar. Fig 7 
illustrates the stroke volume repeatability at low frequency obtained by gravimetry and 
in Fig. 8 it is shown the so called “trumpet curve”, which gives the maximum positive 
and negative percentage deviations from the target dose of 1 U/h at different 
observation intervals.  
 
 
Fig.7: Pneumatic pumping steps of the µ-pump; 
stroke volume repeatability example. 
Fig.8: Trumpet curve of a pump actuated at 1U/h 
(eq. to 0.01 ml/h). 
 
 
Mechanical characteristics were obtained by studying the piezoelectric element 
displacement through optical technique and also by means of cycling pumping tests in 
order to validate valve and pumping membrane reliability. I-V electrical characteristics 
were obtained instead by classical tester measurements, at the probe bench, for 
passive components. 
Figs. 6: Stroke volume versus flow rate (left) and stroke volume versus reservoir pressure (right 
image). 
5. Safety Features and Reliability 
 
The intrinsic safety features are ensured by built-in device sensors conceived to detect 
“in real time” eventual occlusion (coming from the catheter for instance) and other 
anomalies like the presence of air, leaks, incomplete strokes, reservoir under or 
overpressure. In Fig. 9 the typical signal output shape during a stroke is represented 
before, during and after a total occlusion, showing the high sensitivity of the detection 
since only one stroke is necessary to detect this failure. As far as device control is 
concerned, at least four levels of electrical testing are performed: Parametrical Testing 
after active circuitry completion on wafer, Electrical Wafer Sorting on stack performed 
after wafer bonding and before sawing, Functional Testing after pump cell assembly 
and Final Testing once the full device has been produced. Fatigue and stress tests 
certify the pumping cycling capability well above the device lifetime. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
two borophosphosilicate glasses as caps onto an intermediate silicon slice for anodic 
bonding or three silicon wafers for metallic one. The device is finally sawed and 
mounted on a ceramic substrate where the pumping membrane is actuated with an 
external piezoelectric element. In field self diagnosis and safety were studied on the 
pumping volume, electronics and pressures with laboratory characterization and 
reliability tests. The result is a compact, core pump chip that can deliver from 0.02 
Units of insulin up to 3.6 Units per minute with accuracy better than 5%. 
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6. Comment and Conclusions 
 
A new infusion pump concept, based on 
MEMS technology, has been presented, 
able to minimize size and costs, offering a 
high precision pharmacological dispense. 
During the design and technological 
development special effort has been 
dedicated to mechanical simulations, 
process integration, self-diagnosis and 
characterization measurement methods. 
Process integration was developed in 
order to stack three slices:  Fig. 9: Typical detector signal before, 
during and after an occlusion. 
 
